U.S. markets closed

Revance Therapeutics, Inc. (RVNC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.08-0.22 (-0.91%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close24.30
Open24.13
Bid24.04 x 800
Ask24.06 x 800
Day's Range23.75 - 24.44
52 Week Range9.88 - 27.97
Volume173,800
Avg. Volume512,117
Market Cap1.588B
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-4.25
Earnings DateNov 02, 2020 - Nov 06, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est35.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more